We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

75 hedge funds and large institutions have $300M invested in Editas Medicine in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

10% more funds holding

Funds holding: 68 → 75 (+7)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

45% less capital invested

Capital invested by funds: $550M → $300M (-$250M)

63% less call options, than puts

Call options by funds: $44K | Put options by funds: $120K

Holders
75
Holders Change
+7
Holders Change %
+10.29%
% of All Funds
2%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
24
Increased
23
Reduced
15
Closed
15
Calls
$44K
Puts
$120K
Net Calls
-$76K
Net Calls Change
-$76K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.43M
3
SM
Sabby Management
Florida
+$2.77M
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.17M
5
BIT
BlackRock Institutional Trust
California
+$2.15M

Top Sellers

1
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$10.2M
2
AI
Alphabet Inc
California
-$6.26M
3
Jennison Associates
Jennison Associates
New York
-$4.13M
4
EC
EcoR1 Capital
California
-$2.08M
5
Morgan Stanley
Morgan Stanley
New York
-$945K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$586K -$146K -7,110 -14%
Millennium Management
27
Millennium Management
New York
$539K +$499K +24,340 +155%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$520K +$222K +10,812 +39%
HP
29
Harbourvest Partners
Massachusetts
$490K +$745K +36,362 New
Charles Schwab
30
Charles Schwab
California
$485K +$340K +16,610 +86%
TD Asset Management
31
TD Asset Management
Ontario, Canada
$417K +$379K +18,483 +148%
UBS Group
32
UBS Group
Switzerland
$411K +$270K +13,177 +76%
BIM
33
BlackRock Investment Management
Delaware
$356K -$1.29K -63 -0.2%
AllianceBernstein
34
AllianceBernstein
Tennessee
$326K +$156K +7,600 +46%
Victory Capital Management
35
Victory Capital Management
Texas
$299K +$454K +22,180 New
Bessemer Group
36
Bessemer Group
New Jersey
$294K +$447K +21,818 New
HLA
37
Hamilton Lane Advisors
Pennsylvania
$260K +$396K +19,323 New
EA
38
Emerald Acquisition
Washington
$253K +$385K +18,769 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$197K +$4.1K +200 +1%
SSA
40
Schonfeld Strategic Advisors
New York
$189K -$6.76K -330 -2%
AAM
41
Aberdeen Asset Management
United Kingdom
$182K +$276K +13,491 New
TA
42
Teachers Advisors
New York
$148K – – –
EMG
43
Ellington Management Group
Connecticut
$145K +$220K +10,757 New
PCC
44
Park Circle Company
Maryland
$135K +$205K +10,000 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$133K – – –
BA
46
BlackRock Advisors
Delaware
$132K +$20.3K +990 +11%
Group One Trading
47
Group One Trading
Illinois
$118K +$179K +8,721 New
BG
48
BlackRock Group
United Kingdom
$117K +$178K +8,677 New
Simplex Trading
49
Simplex Trading
Illinois
$115K +$176K +8,586 New
HTC
50
Hershey Trust Company
Pennsylvania
$98K +$149K +7,273 New
1
2
3 4

EDIT Hedge Fund Activity: Q3 2016 in Review

75 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2016, worth a combined $300M — down 45% from $550M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 15 closed out — a net gain of 9 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $14.7M. The largest seller was Polaris Venture Management Co VI, cutting an estimated $10.2M.

  • 75 institutional investors held Editas Medicine (EDIT) as of Q3 2016, up from 68 in Q2 2016.
  • Funds reported $300M of Editas Medicine stock for Q3 2016, down 45% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2016 and 15 closed out, a net change of +9 holders.
  • The largest Editas Medicine buyer in Q3 2016 was Vanguard Group, an estimated $14.7M added.
  • The largest Editas Medicine seller in Q3 2016 was Polaris Venture Management Co VI, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2016.